S 1090

Subscribe to Selected New Research on S 1090

10 relevant articles (2 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As:

(6R,7R)-7-((Z)-2-(2-amino-4-thiazolyl)-2-hydroxyiminoacetamido)-8-oxo-3-(1,2,3-triazol-5-yl)thiomethylthio-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; S-1090

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Polycyclic Compounds: 58

Bridged Compounds: 2

Bicyclo Compounds

Heterocyclic Bicyclo Compounds

Related Diseases

1.	Respiratory Tract Infections (Respiratory Tract Infection) 11/01/1995 - "The in vivo efficacy of S-1090 against systemic and urinary and respiratory tract infections caused by gram-positive and -negative bacteria was superior to that expected from the in vitro and in vivo activities of the agents against which it was compared." Get all the results and reference details, order at left...
2.	Endometritis 05/01/1998 - "The in vivo efficacy of S-1090 was evaluated using uterine endometritis of model rats" Get all the results and reference details, order at left...
3.	Fetal Weight 05/01/2001 - "No effects of S-1090 were noted in the number of corpora lutea, number of implantations, implantation rate, death or resorption rate, number of live fetuses, sex ratio of live fetuses, fetal body weight of either sex, incidence of external anomalies, incidence of skeletal anomalies or variations, degree of ossification, or incidence of visceral anomalies" 05/01/2001 - "No effects of S-1090 were observed in the implantation ratio, embryo-fetal viability, fetal body weight, and incidence of external, skeletal and visceral anomalies" Get all the results and reference details, order at left...
4.	Infection 06/01/1998 - "In-vitro activity of S-1090, a novel oral cephalosporin, against bacteria causing infections in obstetric and gynaecological patients." 05/01/1998 - "S-1090 is a promising oral cephalosporin antibiotic for the treatment of infections in the fields of obstetrics and gynecology." Get all the results and reference details, order at left...
5.	Body Weight (Weight, Body) 05/01/2001 - "Body weight gain was increased from the early stage of administration to the end of pregnancy, food consumption was transiently decreased at the early stage of administration, and water consumption was increased from the middle to the end of pregnancy in all the S-1090 dosing groups" 05/01/2001 - "In females, body weight gain was restrained during late pregnancy, and food consumption was decreased transiently following the initiation of dosing, and then remained high on the day before parturition in all the S-1090 dosing groups" Get all the results and reference details, order at left...
11 Diseases and 10 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Antigens
1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>